GEN — Gen Digital Inc. Stock Price, Chart & AI Report

Positive Feb 5, 2026 • 21:05 UTC Benzinga • Prnewswire

Gen Reports Strong Q3 FY26 Results and Raises FY26 Guidance

Gen Digital Inc. (NASDAQ:GEN) reported strong Q3 FY26 results with revenue of $1.24 billion (up 26%), operating income of $629 million (up 9%), and diluted EPS of $0.64 (up 14%). The company raised its full-year FY26 guidance, expecting revenue between $4.955-$4.975 billion and EPS between $2.54-$2.56. The company also approved a quarterly cash dividend of $0.125 per share and deployed nearly $700 million in capital to shareholders during the quarter.

GEN GENVR earnings Q3 results guidance raise revenue growth cybersecurity digital freedom

Sentiment note

Strong Q3 results with 26% revenue growth, 14% EPS growth, and 42% year-to-date free cash flow growth. Company raised full-year FY26 guidance for both revenue and EPS, demonstrating confidence in future performance. Significant capital deployment to shareholders ($700 million) and approval of quarterly dividend further support positive outlook.

Neutral Nov 24, 2025 • 23:34 UTC GlobeNewswire Inc. • Aaron Mendes

Former LifeLock Leader Steve Blackford Joins PrivacyHawk as Chief Marketing Officer

PrivacyHawk, a consumer AI privacy protection company, has appointed Steve Blackford as its new Chief Marketing Officer. Blackford brings over a decade of experience from LifeLock and will lead brand and growth efforts as the company aims to expand its mission of giving consumers control over their personal data.

GEN GENVR privacy data protection cybersecurity AI marketing

Sentiment note

Briefly mentioned as parent company of LifeLock with large customer base, no specific evaluation provided

Unknown Oct 21, 2025 • 13:41 UTC Investing.com • Sam Quirke

3 Oversold Large-Caps That Look Ripe for a Rebound

Three large-cap stocks - Cintas, Fastenal, and Gen Digital - have experienced significant price drops since August but maintain strong fundamental business characteristics, presenting potential investment opportunities for risk-tolerant investors.

CTAS FAST GEN GENVR oversold stocks large-cap market rebound technical analysis

Sentiment note

Stock declined 20% but exceeded earnings expectations, has attractive total addressable market, trading below analyst price targets, and shows oversold technical conditions

Neutral Oct 14, 2025 • 13:49 UTC Benzinga • Prnewswire

Reklaim Hires Former Norton President to Lead Reklaim Protect

Reklaim Ltd. has hired Mark Thompson, former Head of Privacy Product Management at Norton, as Vice President of Product to lead its Reklaim Protect platform, focusing on consumer data privacy and protection.

GEN GENVR data privacy consumer protection privacy product personal information

Sentiment note

Parent company of Norton, mentioned in context of executive's previous experience

Neutral Aug 20, 2025 • 13:27 UTC Benzinga • Prnewswire

Quantum Computing Could Break the Internet. Some Are Already Building the Fix

As quantum computing threatens cybersecurity, companies are developing quantum-resistant technologies to protect digital infrastructure, with projections showing significant market growth in post-quantum cryptography and cybersecurity solutions.

FTNT GEN GENVR FFIV quantum computing cybersecurity post-quantum cryptography AI security

Sentiment note

Reporting on increasing cyber threats and working to develop detection capabilities, but highlighting growing complexity of cybersecurity landscape

Positive Apr 10, 2025 • 20:15 UTC Benzinga • Business Wire

MoneyLion Inc. Stockholders Approve Proposed Acquisition by Gen Digital Inc.

MoneyLion Inc. stockholders have approved the proposed acquisition by Gen Digital Inc. The transaction is expected to close on April 17, 2025, subject to customary closing conditions.

ML ML.WS GEN MoneyLion Gen Digital acquisition

Sentiment note

The article mentions that Gen Digital is acquiring MoneyLion, suggesting a positive sentiment towards the transaction from Gen Digital's perspective.

Positive Dec 9, 2024 • 12:29 UTC Investing.com • Marketbeat.Com

3 Top Cybersecurity Stock Picks for 2025

The article discusses three top cybersecurity stocks for 2025: Rubrik, Gen Digital, and Fortinet. These companies are expected to benefit from the increasing focus on cybersecurity spending across industries.

RBRK GEN FTNT cybersecurity stocks Rubrik Gen Digital Fortinet

Sentiment note

Gen Digital, a relatively smaller player in the cybersecurity industry, has seen strong performance in its recent quarter, with year-over-year increases in revenue, earnings, operating margin, and operating cash flow. The company is also optimistic about future growth, with executives anticipating a 4-5% bookings growth rate for the rest of the fiscal year.

Neutral Sep 4, 2024 • 13:00 UTC GlobeNewswire Inc. • Gainey Mckenna & Egleston

GAINEY McKENNA & EGLESTON Announces Proposed Class Action Settlement on Behalf of Purchasers of Symantec Corporation n/k/a Gen Digital Inc. Common Stock in the Symantec Corporation Employee Stock Purchase Plan - GEN

Symantec Corporation (now Gen Digital Inc.) has agreed to a $850,000 settlement to resolve a class action lawsuit brought by purchasers of the company's stock through its employee stock purchase plan. The lawsuit alleged violations of the Securities Act related to the company's disclosures about its internal controls.

GEN Symantec Corporation Gen Digital Inc. class action lawsuit employee stock purchase plan Securities Act

Sentiment note

Gen Digital Inc. is the new name of Symantec Corporation, and the article treats the two entities as the same for the purposes of the lawsuit and settlement.

Unknown Jun 28, 2024 • 06:00 UTC GlobeNewswire Inc. • Genmab A/S

Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma

Company Announcement

GEN Regulatory information European Regulatory News

Unknown Jun 27, 2024 • 21:00 UTC GlobeNewswire Inc. • Genmab A/S

Completion of Share Buy-back Program

Company Announcement

GEN Changes in company's own shares European Regulatory News

Unknown Jun 26, 2024 • 23:03 UTC GlobeNewswire Inc. • Genmab A/S

EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Company Announcement

GEN Other News European Regulatory News

Unknown Jun 24, 2024 • 13:55 UTC GlobeNewswire Inc. • Genmab A/S

Transactions in Connection with Share Buy-back Program

Company Announcement

GEN Changes in company's own shares European Regulatory News